We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEC
6901
DELISTED
IEC Electronics Corp.
IEC
$19K ﹤0.01%
+2,089
New +$15.8K
GRNVU
6902
DELISTED
GreenVision Acquisition Corp Unit
GRNVU
$19K ﹤0.01%
+1,864
New +$18.8K
VKTXW
6903
DELISTED
Viking Therapeutics, Inc.
VKTXW
$19K ﹤0.01%
2,894
-800
-22% -$4.68K
HCCH
6904
DELISTED
HL Acquisitions Corp. Ordinary Shares
HCCH
$19K ﹤0.01%
1,793
-600
-25% -$6.16K
BUY
6905
DELISTED
USCF SummerHaven SHPEI Index Fund
BUY
$19K ﹤0.01%
893
-225
-20% -$4.51K
BCRH
6906
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$19K ﹤0.01%
2,742
+757
+38% +$5.31K
CTACU
6907
DELISTED
ChaSerg Technology Acquisition Corp. Unit
CTACU
$19K ﹤0.01%
1,600
+1,500
+1,500% +$17K
ENFC
6908
DELISTED
Entegra Financial Corp.
ENFC
$19K ﹤0.01%
634
-5,685
-90% -$171K
CART
6909
DELISTED
Carolina Trust BancShares
CART
$19K ﹤0.01%
1,431
-762
-35% -$8.9K
PLM
6910
DELISTED
PolyMet Mining Corp.
PLM
$19K ﹤0.01%
7,472
+3,186
+74% +$9.66K
CPI
6911
DELISTED
CPI Inflation Hedged ETF
CPI
$19K ﹤0.01%
667
+209
+46% +$5.89K
DDMXU
6912
DELISTED
DD3 Acquisition Corp. Units
DDMXU
$19K ﹤0.01%
1,769
ACEL icon
6913
Accel Entertainment
ACEL
$987M
$18K ﹤0.01%
+1,469
New +$16K
AFK icon
6914
VanEck Africa Index ETF
AFK
$105M
$18K ﹤0.01%
908
AGMH icon
6915
AGM Group Holdings
AGMH
$2.48M
$18K ﹤0.01%
22
-7
-24% -$6.42K
GOLD
6916
Gold.com Inc
GOLD
$1.26B
$18K ﹤0.01%
4,434
+2,864
+182% +$14.7K
CLIR icon
6917
ClearSign Technologies
CLIR
$25.5M
$18K ﹤0.01%
2,347
-552
-19% -$5.37K
ETON icon
6918
Eton Pharmaceutcials
ETON
$1.22B
$18K ﹤0.01%
+2,550
New +$15.8K
EUO icon
6919
ProShares UltraShort Euro
EUO
$34.6M
$18K ﹤0.01%
685
-5,843
-90% -$160K
FUSB icon
6920
First US Bancshares
FUSB
$91.1M
$18K ﹤0.01%
1,550
-1,338
-46% -$13.4K
GILT icon
6921
Gilat Satellite Networks
GILT
$848M
$18K ﹤0.01%
+2,335
New +$18.7K
HBM icon
6922
Hudbay
HBM
$12.3B
$18K ﹤0.01%
4,287
+3,287
+329% +$11.9K
HEPA
6923
DELISTED
Hepion Pharmaceuticals
HEPA
$18K ﹤0.01%
3
-1
-25% -$3.87K
IOR
6924
Income Opportunity Realty Investors
IOR
$18K ﹤0.01%
1,398
-193
-12% -$2.38K
IRIX icon
6925
IRIDEX
IRIX
$14.5M
$18K ﹤0.01%
7,973
+4,823
+153% +$10.2K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.